Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 283,600 shares, a growth of 159.2% from the December 31st total of 109,400 shares. Based on an average daily trading volume, of 739,800 shares, the short-interest ratio is currently 0.4 days. Approximately 23.8% of the company’s stock are short sold.
Autonomix Medical Trading Down 1.3 %
NASDAQ:AMIX opened at $3.05 on Friday. The company has a market capitalization of $3.51 million and a P/E ratio of -0.19. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26. The stock’s 50 day moving average price is $3.79 and its 200 day moving average price is $10.69. Autonomix Medical has a 52 week low of $2.55 and a 52 week high of $121.80.
Autonomix Medical (NASDAQ:AMIX – Get Free Report) last announced its earnings results on Friday, November 8th. The company reported ($2.47) earnings per share (EPS) for the quarter. On average, research analysts forecast that Autonomix Medical will post -10 EPS for the current fiscal year.
Autonomix Medical Company Profile
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Read More
- Five stocks we like better than Autonomix Medical
- Election Stocks: How Elections Affect the Stock Market
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Does Downgrade Mean in Investing?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Effectively Use the MarketBeat Ratings Screener
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.